285 related articles for article (PubMed ID: 9465666)
1. [Immune reaction to human cytomegalovirus].
Ito M
Nihon Rinsho; 1998 Jan; 56(1):62-8. PubMed ID: 9465666
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA.
Fletcher JM; Prentice HG; Grundy JE
J Immunol; 1998 Sep; 161(5):2365-74. PubMed ID: 9725232
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR-restricted cytotoxicity of cytomegalovirus-infected monocytes mediated by Leu-3-positive T cells.
Lindsley MD; Torpey DJ; Rinaldo CR
J Immunol; 1986 Apr; 136(8):3045-51. PubMed ID: 2420881
[TBL] [Abstract][Full Text] [Related]
4. Alloreactive cytotoxic CD4+ responses elicited by cytomegalovirus-infected endothelial cells: role of MHC class I antigens.
Weinberg A; Zhang L; Hayward AR
Viral Immunol; 2000; 13(1):37-47. PubMed ID: 10733167
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus (CMV)-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes.
Gehrz RC; Rutzick SR
Clin Exp Immunol; 1985 Jul; 61(1):80-9. PubMed ID: 2994924
[TBL] [Abstract][Full Text] [Related]
6. Cytokine-mediated induction of endothelial adhesion molecule and histocompatibility leukocyte antigen expression by cytomegalovirus-activated T cells.
Waldman WJ; Knight DA
Am J Pathol; 1996 Jan; 148(1):105-19. PubMed ID: 8546198
[TBL] [Abstract][Full Text] [Related]
7. Modulation of HLA expression in human cytomegalovirus immune evasion.
Lin A; Xu H; Yan W
Cell Mol Immunol; 2007 Apr; 4(2):91-8. PubMed ID: 17484802
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection.
López-Botet M; Angulo A; Gumá M
Tissue Antigens; 2004 Mar; 63(3):195-203. PubMed ID: 14989708
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
[TBL] [Abstract][Full Text] [Related]
10. [Anti-cytomegalovirus T-cell immunity and HLA restriction in the transplanted kidney patient].
Charpentier B; Michelson S; Lantz O; Hiesse C; Martin B; Fries D
Ann Med Interne (Paris); 1987; 138(5):334-7. PubMed ID: 2823657
[TBL] [Abstract][Full Text] [Related]
11. CMV infection is associated with the depletion but lack of activation of peripheral blood natural killer cells in a lung transplant cohort.
Fildes JE; Walker AH; Williams SG; Yonan N; Leonard CT
Transpl Immunol; 2008 Jul; 19(3-4):235-7. PubMed ID: 18583135
[TBL] [Abstract][Full Text] [Related]
12. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells.
Reyburn HT; Mandelboim O; Valés-Gómez M; Davis DM; Pazmany L; Strominger JL
Nature; 1997 Apr; 386(6624):514-7. PubMed ID: 9087413
[TBL] [Abstract][Full Text] [Related]
13. ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells.
Kubin M; Cassiano L; Chalupny J; Chin W; Cosman D; Fanslow W; Müllberg J; Rousseau AM; Ulrich D; Armitage R
Eur J Immunol; 2001 May; 31(5):1428-37. PubMed ID: 11465099
[TBL] [Abstract][Full Text] [Related]
14. The cytolytic T lymphocyte response to the murine cytomegalovirus. I. Distinct maturation stages of cytolytic T lymphocytes constitute the cellular immune response during acute infection of mice with the murine cytomegalovirus.
Reddehase MJ; Keil GM; Koszinowski UH
J Immunol; 1984 Jan; 132(1):482-9. PubMed ID: 6317749
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity against CMV-infected fibroblasts in pediatric patients transplanted with CD34(+)-selected allografts from alternative donors.
Lang P; Griesinger A; Hamprecht K; Feuchtinger T; Schumm M; Neuhäuser F; Greil J; Martin D; Handgretinger R; Niethammer D
Hum Immunol; 2004 May; 65(5):423-31. PubMed ID: 15172441
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load.
Reusser P; Cathomas G; Attenhofer R; Tamm M; Thiel G
J Infect Dis; 1999 Aug; 180(2):247-53. PubMed ID: 10395836
[TBL] [Abstract][Full Text] [Related]
17. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
Bakker AB; Phillips JH; Figdor CG; Lanier LL
J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
[TBL] [Abstract][Full Text] [Related]
18. A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects.
Berencsi K; Gyulai Z; Gönczöl E; Pincus S; Cox WI; Michelson S; Kari L; Meric C; Cadoz M; Zahradnik J; Starr S; Plotkin S
J Infect Dis; 2001 Apr; 183(8):1171-9. PubMed ID: 11262198
[TBL] [Abstract][Full Text] [Related]
19. Protective immunity transferred by infusion of cytomegalovirus-specific CD8(+) T cells within donor grafts: its associations with cytomegalovirus reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation.
Luo XH; Huang XJ; Liu KY; Xu LP; Liu DH
Biol Blood Marrow Transplant; 2010 Jul; 16(7):994-1004. PubMed ID: 20167279
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus (CMV)-specific cellular immune responses.
Harari A; Zimmerli SC; Pantaleo G
Hum Immunol; 2004 May; 65(5):500-6. PubMed ID: 15172450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
